Key statistics
As of last trade Pulmonx Corp (4NI:DUS) traded at 1.17, 7.34% above its 52-week low of 1.09, set on Nov 21, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.17 |
|---|---|
| High | 1.20 |
| Low | 1.17 |
| Bid | 1.16 |
| Offer | 1.18 |
| Previous close | 1.24 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 41.25m |
| Free float | 36.81m |
| P/E (TTM) | -- |
| Market cap | 59.81m USD |
| EPS (TTM) | -1.41 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 15:31 GMT.
More ▼
Announcements
- Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Pulmonx Reports Third Quarter 2025 Financial Results
- Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
- Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025
- Pulmonx to Participate in September Investor Conferences
- Pulmonx Reports Second Quarter 2025 Financial Results
- Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference
- Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025
- Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
- Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference
More ▼
